StockData
Aardvark Therapeutics, Inc. logo

Aardvark Therapeutics, Inc. (AARD) stock

AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.15−0.11 (-8.73%)

Close on Nov 17, 2026Market cap $25.17MP/E –Yield –

Aardvark Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Aardvark Therapeutics's price to book ratio was 0.5× on Nov 11, 2026, against 1.8× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×−1.9
2025Dec 31, 20252.3×–

More Aardvark Therapeutics figures

See a number that looks wrong?